RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ARTEMETHER AND LUMIFANTRINE IN PURE AND MARKETED FORMULATION

Journal Title: Int J of Pharm Res & Analy - Year 2016, Vol 6, Issue 1

Abstract

 ABSTRACT A simple, rapid, precise and accurate reversed phase high performance liquid chromatographic method has been developed for the simultaneous determination of Artemether in combination with Lumefantrine. This method uses a Hypersil ODS C18(4.6×150mm,5μ particle Size) analytical column, a mobile phase of methanol: ammonium acetate buffer pH 3 adjusted with orthophosphoric acid in ratio(65:35 v/v). The instrumental settings are a flow rate of 1.2 ml/min and PDA detector wavelength at 256 nm. The retention times for Artemether and Lumefantrine were 2.8 min and 3.8 min, respectively. The method is validated and shown to be linear. The linearity range for Artemether and Lumefantrine were 10-50μg/ml & 60-300μg/ml respectively. The Percentage recovery for Artemether and Lumefantrine are ranged between 99–102 and 99–102 respectively. The correlation coefficients of Artemether and Lumefantrine were 0.999, and 0.999, respectively. The relative standard deviation for six replicates is always less than 2%. The Statistical analysis proves that the method is suitable for routine analysis of Artemether and Lumefantrine as a bulk drug and in pharmaceutical formulation. Keywords: Artemether, Lumefantrine, RP-HPLC and Validation.

Authors and Affiliations

D. Chinababu* and M. Sreenivasulu

Keywords

Related Articles

 A VALIDATED SIMULTANEOUS ESTIMATION OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE BY UV – SPECTROPHOTOMETRIC METHOD IN BULK AND FORMULATION

 A simple and rapid UV – Spectrophotometric method was developed and validated for the simultaneous estimation of Doxylamine succinate and Pyridoxine HCl in combined dosage forms. The said combination is used in tre...

 RECENT APPROCHES FOR IMPURITY PROFILING IN PHARMACEUTICAL FORMULATIONS

 In the pharmaceutical world, an impurity is considered as any other organic material, besides the drug substance, or ingredients, arise out of synthesis or unwanted chemicals that remains with API’s. The impurity m...

 A SENSITIVE RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ATORVASTATIN CALCIUM, FENOFIBRATE, AND ORLISTAT IN TABLET DOSAGE FORM

 A simple, sensitive and reproducible method was developed and validated for the simultaneous estimation of Atorvastatin calcium, Fenofibrate, and Orlistat in tablet formulation by reverse phase high performance liq...

 METHOD DEVELOPMENT AND VALIDATION OF OLMESARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMBINED TABLET DOSAGE FORM

 A simple, accurate, precise, economical and reproducible method was developed for simultaneous estimation of  olmesartan, amlodipine and hydrochlorothiazide in bulk and its dosage form. The excipients in the c...

 RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF METFORMIN AND SITAGLIPTIN IN TABLET DOSAGE FORMS

A new simple and precise reverse phase high performance liquid chromatographic method has been developed andsubsequently validated for the simultaneous estimation of Metformin and Sitagliptin in combination. The chromato...

Download PDF file
  • EP ID EP133513
  • DOI -
  • Views 140
  • Downloads 0

How To Cite

D. Chinababu* and M. Sreenivasulu (2016).  RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS ESTIMATION OF ARTEMETHER AND LUMIFANTRINE IN PURE AND MARKETED FORMULATION. Int J of Pharm Res & Analy, 6(1), 16-21. https://europub.co.uk/articles/-A-133513